Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 11, 2014, Pages 4055-4061

  Detsch, Rainer ^a   Stoor, Patricia ^b   Grünewald, Alina ^a   Roether, Judith A ^a   Lindfors, Nina C ^b   Boccaccini, Aldo R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bioactive glass; Bone tissue engineering; Fibroblast; Vascularization; VEGF

Indexed keywords

BONE; CELL CULTURE; CELL ENGINEERING; ENDOTHELIAL CELLS; FIBROBLASTS; GRANULATION; PARTICLE SIZE; REPAIR; TISSUE ENGINEERING;

BONE REGENERATION; BONE TISSUE ENGINEERING; HUMAN FIBROBLAST CELLS; LACTATE DEHYDROGENASE; NEO-VASCULARIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION; VEGF;

BIOACTIVE GLASS;

BIOACTIVE GLASS; BIOMATERIAL; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN; BIOACTIVE GLASS S53P4; GLASS; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; BONE REGENERATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; PARTICLE SIZE; BIOSYNTHESIS; BONE; CELL LINE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; SECRETION (PROCESS);

BONE AND BONES; CELL LINE; FIBROBLASTS; GENE EXPRESSION REGULATION; GLASS; HUMANS; L-LACTATE DEHYDROGENASE; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908062498     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35069     Document Type: Article

References (36)

1. Virolainen P, Heikkila J, Yli-Urpo A, Vuorio E, Aro HT. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res A 1997;35:9-17.
2. Hench LL, Paschall HA. Direct chemical bond of bioactive glassceramic materials to bone and muscle. J Biomed Mater Res 1973; 7:25-42.
3. Rahaman MN, Day DE, Sonny Bal B, Fu Q, Jung SB, Bonewald LF, Tomsia, AP. Bioactive glass in tissue engineering. Acta Biomater 2011;7:2355-2373.
4. Jones JR. Review of bioactive glass: From Hench to hybrids. Acta Biomater 2013;9:4457-4486.
5. Gerhardt LC, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials 2010;3:3867-3910.
6. Hoppe A, Güldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011;32:2757-2774.
7. Andersson Ö. The bioactivity of silicate glass. PhD Thesis. Finland: AboAkademi University, 1990.
8. Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med 2008;19:27-32.
9. Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylänen H, Hupa M, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med 2008;19:547-551.
10. Stoor P, Söderling E, Andersson OH, Yli-Urpo A. Interactions between the frontal sinusitis-associated pathogen Heamophilus influenzae and the bioactive glass S53P4. Bioceramics 1995;8:253-258.
11. Stoor P, Söderling E, Grénman R. Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism Klebsiellaozaenae. J Biomed Mater Res 1999;48:869-874.
12. Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral micro-organisms. Acta Odontol Scand 1998;56:161-165.
13. Stoor P, Pulkkinen J, Grénman R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Annal Otol Rhinol Laryngol 2010;119:377-382.
14. Silvola JT. Mastoidectomy cavity obliteration with bioactive glass: A pilot study. Otolaryngol: Head Neck Surg 2011;145:96-97.
15. Sarin J, Grénman R, Aitasalo K, Pulkkinen J. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Annal Otol Rhinol Laryngol 2012;121: 563-569.
16. Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A. Bioactive glass S53P4 in frontal sinus obliteration: A long-term clinical experience. Head Neck 2006;28:834-841.
17. Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors. J Biomed Mater Res B 2010;94:157-164.
18. Lindfors NC, Hyvönen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, Salo J. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010;47:212-218.
19. Rantakokko J, Frantzén J, Heinänen J, Kajander S, Kotilainen E, Gullichsen E, Lindfors NC. Posterolateral spondylodesis using bioactive glass S53P4 and autogenous bone in instrumented unstable lumbar spine burst fractures: A prospective 10-year follow- up study. Scand J Surg 2012;101:66-71.
20. Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008;15:100.
21. Leu A, Stieger SM, Dayton P, Ferrara KW, Leach JK. Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng A 2009;15:877-885.
22. Leu A, Leach JK. Proangiogenic potential of a collagen-bioactive glass substrate. Pharm Res 2008;25:1222.
23. Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, Gabe SM. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 2004; 25:5857-5866.
24. Gorustovich A, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: A review of in vitro and in vivo evidences. Tissue Eng B 2010;16:199-207.
25. Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 2005;11: 768-777.
26. Gerhardt LC, Widdows KL, Erol MM, Burch CW, Sanz-Herrera J, Ochoa I, Stämpfli R. The pro-angiogenic properties of multifunctional bioactive glass composite scaffolds. Biomaterials 2011; 32:4096-4108.
27. Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by guided tissue regeneration. Plast Reconstruct Surg 1988;81: 672-676.
28. Kalfas IH. Principles of bone healing. Neurosurg Focus 2001;10: 7-10.
29. Nguyen LH, Annabi N, Nikkhah M, Bae H, Binan L, Park S, Kang Y, Yang Y, Khademhosseini A. Vascularized bone tissue engineering: Approaches for potential improvement. Tissue Eng B 2012; 18:363-382.
30. Zachary I. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 2003;31:1171-1177.
31. Keshaw H, Forbes A, Day RM. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials 2005;26:4171-4179.
32. Greenspan DC, Zhong JP, La Torre GP. The evaluation of surface structure of bioactive glasses in-vitro. In: Wilson J, Hench LL, Greenspan D. Bioceramics Vol 8 Pergamon: Elsevier Science Ltd; 1995, p. 89-91.
33. Fagerlund S, Ek P, Hupa L, Hupa M. Dissolution kinetics of a bioactive glass by continuous measurement. J Am Ceram Soc 2012; 10:1-8.
34. Arkudas A, Balzer A, Buehrer G, Arnold I, Hoppe A, Detsch R, Newby P, Fey T, Greil P, Horch RE, Boccaccini AR, Kneser U. Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng C 2013;19:479-486.
35. Aguirre A, Gonzalez A, Planell JA, Engel E. Extracellular calcium modulates in vitro bone marrow-dervied Flk-11 CD341 progenitor cell chemotaxis and differentiation through a calcium-sensing receptor. Biochem Biophys Res Comm 2010;393:156-161.
36. Wu Q, Shao H, Eton D, Li J, Yang B, Webster KA, Yu H. Extracellular calcium increases CXCR4 expression on bone marrowderived cells and enhances pro-angiogenesis therapy. J Cell Mol Med 2009;13:3764-3773.